" /> Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240 - CISMeF





Preferred Label : Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240;

NCIt synonyms : Allogeneic Red Cells Expressing 4-1BBL and IL-15TP; Engineered RBCs Co-expressing 4-1BBL and IL-15TP RTX-240;

NCIt definition : A preparation of allogeneic, off-the-shelf (OTS) red blood cells (RBCs) engineered to express both the co-stimulatory molecule tumor necrosis factor ligand superfamily (TNFSF) member 9 (TNFSF9; 4-1BBL) and a fusion protein composed of the trans-presented cytokine interleukin (IL)-15/IL-15-receptor alpha (IL-15Ra) (IL-15TP) with potential modulating and antineoplastic activities. CD34 hematopoietic precursor cells (HPC) are collected by apheresis from a healthy O negative donor, purified, and engineered with a lentiviral vector to express 4-1BBL and IL-15TP. The cells are then further expanded and differentiated until the nucleus is ejected, resulting in a mature reticulocyte. Upon administration of the engineered red blood cells co-expressing 4-1BBL and IL-15TP RTX-240, the RBCs express both 4-1BBL and IL-15TP on their cell surfaces. 4-1BBL and IL-15TP bind to and subsequently induce the proliferation and activation of natural killer (NK) cells and T-cells. This enhances the secretion of cytokine interferon-gamma (IFN-g) and results in the induction of an anti-tumor immune response.;

Molecule name : RTX-240; RTX 240;

NCI Metathesaurus CUI : CL1406781;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.